KDM3B anticorps (Center)

N° du produit ABIN500076

Détail du produit anti-KDM3B anticorps

Antigène: KDM3B (Lysine (K)-Specific Demethylase 3B (KDM3B))

Épitope: Center

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp KDM3B est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Specificité: This antibody detects JMJD1B. It will not cross-react with JMJD1A or JMJD1C.

Réactivité croisée (Details): Species reactivity (tested):Human, mouse, rat

Purification: Peptide affinity chromatography

Immunogène: JMJD1B antibody was raised against a 20 amino acid peptide from near the center of human JMJD1B.

Isotype: IgG

Information d'application

Indications d'application: ELISA. Western blot: 1 - 2 μg/mL. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Buffer: PBS containing 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.

Détails sur KDM3B

Antigène: KDM3B (Lysine (K)-Specific Demethylase 3B (KDM3B))

Autre désignation: JMJD1B / KDM3B (KDM3B Produits)

Synonymes: anticorps KDM3B, anticorps JMJD1B, anticorps 5830462I21Rik, anticorps JHDM2B, anticorps Jmjd1b, anticorps mKIAA1082, anticorps 5qNCA, anticorps C5orf7, anticorps NET22, anticorps lysine demethylase 3B, anticorps lysine (K)-specific demethylase 3B, anticorps lysine-specific demethylase 3B, anticorps KDM3B lysine (K)-specific demethylase 3B, anticorps KDM3B, anticorps LOC100540242, anticorps kdm3b, anticorps Kdm3b

Sujet: The jumonji domain containing 1B protein (JMJD1B) was originally discovered as a candidate for the myeloid leukemia tumor suppressor gene. Besides CD34+ cells and acute myeloid leukemia (AML) cell lines, JMJD1B mRNA is highly expressed in liver, heart, kidney, skeletal muscle, and placenta tissues. The JMJD1B gene is localized to a region of chromosome 5q31, which is frequently deleted in myeloid leukemias and myelodysplasias and expression of JMJD1B in a del(5q) cell line results in suppression of clonogenic growth suggesting that JMJD1B may function as a tumor suppressor. In contrast, JMJD1B gene copy number and mRNA expression level was increased in several non-small cell lung cancers indicating that the role of JMJD1B in cancer formation and progression is more complex than originally postulated. At least three isoforms of JMJD1B are known to exist.Synonyms: 5qNCA, C5orf7, JHDM2B, JmjC domain-containing histone demethylation protein 2B, Jumonji domain-containing protein 1B, KIAA1082, Lysine-specific demethylase 3B, Nuclear protein 5qNCA

ID gène: 51780

NCBI Accession: NP_057688

UniProt: Q7LBC6

Pathways: L'effet Warburg